1. Home
  2. HCM vs PACS Comparison

HCM vs PACS Comparison

Compare HCM & PACS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCM
  • PACS
  • Stock Information
  • Founded
  • HCM 2000
  • PACS 2013
  • Country
  • HCM Hong Kong
  • PACS United States
  • Employees
  • HCM N/A
  • PACS N/A
  • Industry
  • HCM Biotechnology: Pharmaceutical Preparations
  • PACS
  • Sector
  • HCM Health Care
  • PACS
  • Exchange
  • HCM Nasdaq
  • PACS Nasdaq
  • Market Cap
  • HCM 2.3B
  • PACS 2.1B
  • IPO Year
  • HCM N/A
  • PACS 2024
  • Fundamental
  • Price
  • HCM $13.52
  • PACS $14.31
  • Analyst Decision
  • HCM Hold
  • PACS Strong Buy
  • Analyst Count
  • HCM 1
  • PACS 9
  • Target Price
  • HCM $19.00
  • PACS $33.22
  • AVG Volume (30 Days)
  • HCM 85.0K
  • PACS 500.2K
  • Earning Date
  • HCM 02-26-2025
  • PACS 02-16-2025
  • Dividend Yield
  • HCM N/A
  • PACS N/A
  • EPS Growth
  • HCM N/A
  • PACS 82.79
  • EPS
  • HCM N/A
  • PACS 0.68
  • Revenue
  • HCM $610,806,000.00
  • PACS $3,558,953,000.00
  • Revenue This Year
  • HCM N/A
  • PACS $30.36
  • Revenue Next Year
  • HCM $18.76
  • PACS $16.86
  • P/E Ratio
  • HCM N/A
  • PACS $21.05
  • Revenue Growth
  • HCM N/A
  • PACS 205.08
  • 52 Week Low
  • HCM $13.00
  • PACS $12.54
  • 52 Week High
  • HCM $21.92
  • PACS $43.92
  • Technical
  • Relative Strength Index (RSI)
  • HCM 40.71
  • PACS N/A
  • Support Level
  • HCM $13.10
  • PACS N/A
  • Resistance Level
  • HCM $13.92
  • PACS N/A
  • Average True Range (ATR)
  • HCM 0.38
  • PACS 0.00
  • MACD
  • HCM 0.02
  • PACS 0.00
  • Stochastic Oscillator
  • HCM 37.96
  • PACS 0.00

About HCM HUTCHMED (China) Limited

HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.

About PACS PACS Group Inc. Common Stock

PACS Group Inc is a post-acute healthcare company primarily focused on delivering high-quality skilled nursing care through a portfolio of independently operated facilities Its is a nursing providers in the United States based on number of facilities, with over 200 post-acute care facilities across nine states serving over 20,000 patients daily. It also provide senior care, assisted living, and independent living options in some of communities.

Share on Social Networks: